Titan Medical (TMDI) Stock Price, News & Analysis

Company Overview

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.13 to $0.15
• 50-Day Range: $0.13 to $0.89
• 52-Week Range: $0.13 to $1.20
• Volume: 7.71 million shs
• Average Volume: 4.83 million shs
• Market Capitalization: $15.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TMDI Stock Analysis - Frequently Asked Questions

How were Titan Medical's earnings last quarter?

Titan Medical Inc. (NASDAQ:TMDI) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.02.

What other stocks do shareholders of Titan Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Titan Medical investors own include NIO (NIO), Tesla (TSLA), Advanced Micro Devices (AMD), FuelCell Energy (FCEL), Micron Technology (MU), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TMDI
• CIK: 840551
• Web: www.titanmedicalinc.com
• Phone: (416) 548-7522
• Fax: N/A
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$14.86 million
• Net Margins: N/A
• Pretax Margin: -209.87%
• Return on Equity: -167.03%
• Return on Assets: -112.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.41
• Quick Ratio: 1.41

Sales & Book Value

• Annual Sales: $20.09 million
• Price / Sales: 0.78
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.32 per share
• Price / Book: 0.44

Miscellaneous

• Outstanding Shares: 111,950,000
• Free Float: 111,932,000
• Market Cap: $15.67 million
• Optionable: Not Optionable
• Beta: 2.36